Synthesis of lanthanide(III) complexes appended with a diphenylphosphinamide and their interaction with human serum albumin

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 71, Issue 3-4, 2011, Pages 435-444

  Giardiello, Marco ^a   Botta, Mauro ^b   Lowe, Mark P ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Contrast agents; Diphenylphosphinamides; Europium(III); Gadolinium(III); Luminescence; Magnetic resonance imaging

Indexed keywords

EID: 84856305219     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-011-0009-4     Document Type: Article

References (48)

1. P Caravan JJ Ellison TJ McMurry RB Lauffer 1999 Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications Chem. Rev. 99 2293 2352 10.1021/cr980440x 1:CAS:528:DyaK1MXlt12rsrg%3D
2. Merbach, A.E.; Toth, E.: The Chemistry Of Contrast Agents In Medical Magnetic Resonance Imaging. John Wiley & Sons, Chichester (2001)
3. V Jacques JF Desreux 2002 New classes of MRI contrast agents Top. Curr. Chem. 221 123 164 10.1007/3-540-45733-X-5 1:CAS:528:DC%2BD38XivVGrur4%3D
4. P Caravan 2006 Strategies for increasing the sensitivity of gadolinium based MRI contrast agents Chem. Soc. Rev. 35 512 523 10.1039/b510982p 1:CAS:528:DC%2BD28XkvFOitLo%3D
5. MP Lowe D Parker O Reany S Aime M Botta G Castellano E Gianolio R Pagliarin 2001 pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation J. Am. Chem. Soc. 123 7601 7609 10.1021/ja0103647 1:CAS:528:DC%2BD3MXltFCmsrs%3D
6. S Zhang K Wu AD Sherry 1999 A novel pH-sensitive MRI contrast agent Angew. Chem. Int. Ed. 38 3192 3194 10.1002/(SICI)1521-3773(19991102)38: 21<3192::AID-ANIE3192>3.0.CO;2-# 1:CAS:528:DyaK1MXns1aqsbg%3D
7. S Aime P Ascenzi E Comoglio M Fasano S Paoletti 1995 Molecular recognition of r-states and t-states of human adult hemoglobin by a paramagnetic Gd(III) complex by means of the measurement of solvent water proton relaxation rate J. Am. Chem. Soc. 117 9365 9366 10.1021/ja00141a034 1:CAS:528: DyaK2MXns1Citrk%3D
8. Giardiello, M. Lowe, M. P.; Botta, M.: An esterase-activated magnetic resonance contrast agent. Chem. Commun. 4044-4046 (2007)
9. M Giardiello MP Lowe 2009 Luminescence study of Eu(III) analogues of esterase-activated magnetic resonance contrast agents Inorg. Chem. 48 8515 8522 10.1021/ic901284t 1:CAS:528:DC%2BD1MXps1Kntr4%3D
10. AJ Surman CS Bonnet MP Lowe GD Kenny JD Bell E Tóth R Vilar 2011 A pyrophosphate-responsive gadolinium(III) MRI contrast agent Chem. Eur. J. 17 223 230 10.1002/chem.201001397 1:CAS:528:DC%2BC3MXit1Omsw%3D%3D
11. W Li G Parigi M Fragai 2002 Luchinat C.; Meade, T J.: Mechanistic studies of a calcium-dependent MRI contrast agent Inorg. Chem. 41 4018 4024 10.1021/ic0200390 1:CAS:528:DC%2BD38XkvVGnu7o%3D
12. MP Lowe 2002 MRI Contrast agents: the next generation Aust. J. Chem. 55 551 556 10.1071/CH02172 1:CAS:528:DC%2BD38XoslKntL8%3D
13. Banci, L.; Bertini, I.; Luchinat, C.: Nuclear and Electron Relaxation. VCH, Weinheim (1991)
14. S Aime M Botta M Fasano E Terreno 1998 Lanthanide(III) chelates for NMR biomedical applications Chem. Soc. Rev. 27 19 29 10.1039/a827019z 1:CAS:528:DyaK1cXjsFOqtQ%3D%3D
15. LJM Kroft 1999 de Roos, A.: Blood pool contrast agents for cardiovascular MR imaging. J. Magn. Reson Imaging 10 395 403 1:STN:280:DyaK1Mvjsl2htw%3D%3D
16. RB Clarkson 2002 Blood Pool MRI Contrast Agents: Properties and Characterisation Top Curr. Chem. 221 201 235 10.1007/3-540-45733-X-7 1:CAS:528:DC%2BD38XivVGrurw%3D
17. Arlart, I.P.; Bongartz, G.M.; Marchal, G.: Magnetic Resonance Angiography, 2nd edn. Springer, Berlin (2002)
18. S Curry H Mandelkow P Brick N Franks 1998 Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites Nat. Struct. Mol. Biol. 5 827 835 10.1038/1869 1:CAS:528:DyaK1cXlvVyhs7w%3D
19. Peters, T.J.: All About Albumin: Biochemistry, Genetics and Medical Applications. Academic Press, San Diego (1996)
20. S Curry P Brick NP Franks 1999 Fatty acid binding to human serum albumin: new insights from crystallographic studies Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 1441 131 140 1:CAS:528:DyaK1MXns1Sgs7Y%3D
21. RB Lauffer 1991 Targeted relaxation enhancement agents for MRI Magn. Reson. Med. 22 339 342 10.1002/mrm.1910220237 1:STN:280:DyaK383lt1Kkuw%3D%3D
22. TN Parac-Vogt K Kimpe S Laurent L Vander Elst C Burtea F Chen RN Muller Y Ni A Verbruggen K Binnemans 2005 Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity Chem. Eur. J. 11 3077 3085 10.1002/chem.200401207 1:CAS:528:DC%2BD2MXksFarsbc%3D
23. S Aime E Gianolio D Longo R Pagliarin C Lovazzano M Sisti 2005 New insights for pursuing high relaxivity MRI agents from modelling the binding interaction of Gd-III chelates to HSA ChemBioChem 6 818 820 10.1002/cbic. 200400364 1:CAS:528:DC%2BD2MXksFajsLw%3D
24. Avedano, S.; Tei, L.; Lombardi, A.; Giovenzana, G. B.; Aime, S.; Longo, D.;Botta, M.: Maximizing the relaxivity of HSA-bound gadolinium complexes by simultaneous optimization of rotation and water exchange. Chem. Commun. 4726-4728 (2007)
25. 2- derivatives Inorg. Chem. 50 1275 1287 10.1021/ic101799c 1:CAS:528:DC%2BC3MXosV2jtg%3D%3D
26. RB Lauffer DJ Parmelee HS Ouellet RP Dolan H Sajiki DM Scott PJ Bernard EM Buchanan KY Ong Z Tyeklar KS Midelfort TJ McMurry RC Walovitch 1996 MS-325: A small-molecule vascular imaging agent for magnetic resonance imaging Acad. Radiol. 3 S356 S358 10.1016/S1076-6332(96)80583-6
27. RB Lauffer DJ Parmelee SU Dunham HS Ouellet RP Dolan S Witte TJ McMurry RC Walovitch 1998 MS-325: Albumin-targeted contrast agent for MR angiography Radiology 207 529 538 1:STN:280:DyaK1c3jvVeltQ%3D%3D
28. DJ Parmelee RC Walovitch HS Ouellet RB Lauffer 1997 Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging Invest. Radiol. 32 741 747 10.1097/00004424-199712000-00004 1:CAS:528:DyaK2sXnvFGhtbk%3D
29. P Caravan NJ Cloutier MT Greenfield SA McDermid SU Dunham JWM Bulte JC Amedio RJ Looby RM Supkowski WD Horrocks TJ McMurry RB Lauffer 2002 The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates J. Am. Chem. Soc. 124 3152 3162 10.1021/ja017168k 1:CAS:528:DC%2BD38XhsV2ht78%3D
30. P Caravan C Comuzzi W Crooks TJ McMurry GR Choppin SR Woulfe 2001 Thermodynamic stability and kinetic inertness of MS-325, a new blood pool agent for magnetic resonance imaging Inorg. Chem. 40 2170 2173 10.1021/ic001117r 1:CAS:528:DC%2BD3MXitFent7w%3D
31. JH Rapp SD Wolff SF Quinn JA Soto SG Meranze S Muluk J Blebea SP Johnson NM Rofsky A Duerinckx GS Foster KC Kent G Moneta MR Middlebrook VR Narra BD Toombs J Pollak EK Yucel K Shamsi RM Weisskoff 2005 Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: Safety and efficacy of gadofosveset-enhanced MR angiography-Multicenter comparative phase III study Radiology 236 71 78 10.1148/radiol.2361040148
32. P Caravan 2009 Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action Acc. Chem. Res. 42 851 862 10.1021/ar800220p 1:CAS:528:DC%2BD1MXhvFGgtLs%3D
33. SG Zech HB Eldredge MP Lowe P Caravan 2007 Protein binding to lanthanide(III) complexes can reduce the water exchange rate at the lanthanide Inorg. Chem. 46 3576 3584 10.1021/ic070011u 1:CAS:528:DC%2BD2sXjvFyju7s%3D
34. S Dumas V Jacques W-C Sun JS Troughton JT Welch JM Chasse H Schmitt-Willich P Caravan 2010 High relaxivity magnetic resonance imaging contrast agents part 1 impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes Invest. Radiol. 45 600 612 10.1097/RLI.0b013e3181ee5a9e 1:CAS:528:DC%2BC3cXhtFOktLbF
35. V Jacques S Dumas W-C Sun JS Troughton MT Greenfield P Caravan 2010 High-relaxivity magnetic resonance imaging contrast agents Part 2 optimization of inner- and second-sphere relaxivity Invest. Radiol. 45 613 624 10.1097/RLI.0b013e3181ee6a49 1:CAS:528:DC%2BC3cXhtFOktLfM
36. R Ramage D Hopton MJ Parrott GW Kenner GA Moore 1984 Phosphinamides-a new class of amino protecting groups in peptide-synthesis J. Chem. Soc. Perkin Trans. 1 6 1357 1370 10.1039/p19840001357
37. HMI Osborn AA Cantrill JB Sweeney 1994 Howson, W.: Direct preparation of n-diphenylphosphinoyl aziridines from 1, 2-aminoalcohols utilizing nucleofugacity of diphenylphosphinates Tetrahedron Lett. 35 3159 3162 10.1016/S0040-4039(00)76856-0 1:CAS:528:DyaK2cXkvVenu78%3D
38. AA Cantrill HMI Osborn JB Sweeney 1998 Preparation and ring-opening reactions of N-diphenylphosphinyl aziridines Tetrahedron 54 2181 2208 10.1016/S0040-4020(97)10430-6 1:CAS:528:DyaK1cXht1akurw%3D
39. Hamblin, J.; Abboyi, N.; Lowe, M. P.: A binaphthyl-containing Eu(III) complex and its interaction with human serum albumin: a luminescence study. Chem. Commun. 657-659 (2005)
40. S Aime M Botta M Fasano E Terreno 1993 Paramagnetic Gd-III-Fe-III heterobimetallic complexes of dtpa-bis-salicylamide Spectrchim. Acta 49A 1315 1322 10.1016/0584-8539(93)80039-D 1:CAS:528:DyaK3sXmsVSgurk%3D
41. A Beeby IM Clarkson RS Dickins S Faulkner D Parker L Royle AS de Sousa JAG Williams M Woods 1999 Non-radiative deactivation of the excited states of europium, terbium and ytterbium complexes by proximate energy-matched OH, NH and CH oscillators: an improved luminescence method for establishing solution hydration states J. Chem. Soc. Perkin Trans. 2 493 503
42. W Horrocks Jr W De DR Sudnick 1979 Lanthanide ion probes of structure in biology-laser-induced luminescence decay constants provide a direct measure of the number of metal-coordinated water-molecules J. Am. Chem. Soc. 101 334 340 10.1021/ja00496a010 1:CAS:528:DyaE1MXpvFClsg%3D%3D
43. Beeby, A.; Bushby, L.M.; Maffeo, D.; Williams, J.A.G.: Intramolecular sensitisation of lanthanide(III) luminescence by acetophenone-containing ligands: the critical effect of para-substituents and solvent. J. Chem. Soc. Dalton Trans. (1), 48-54 (2002)
44. S Aime E Gianolio E Terreno GB Giovenzana R Pagliarin M Sisti G Palmisano M Botta MP Lowe D Parker 2000 Ternary Gd(III)L-HSA adducts: evidence for the replacement of inner-sphere water molecules by coordinating groups of the protein. Implications for the design of contrast agents for MRI J. Biol. Inorg. Chem. 5 488 497 1:CAS:528:DC%2BD3cXmsVOjsbc%3D
45. P Caravan G Pairigi JM Chasse NJ Cloutier JJ Ellison RB Lauffer C Luchinat SA McDermid M Spiller TJ McMurry 2007 Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent Inorg. Chem. 46 6632 6639 10.1021/ic700686k 1:CAS:528:DC%2BD2sXns1Cgsbw%3D
46. S Aime M Botta M Panero M Grandi F Uggeri 1991 Inclusion complexes between beta-cyclodextrin and beta-benzyloxy-alpha-propionic derivatives of paramagnetic dota-Gd(III) and DTPA-Gd(III) complexes Magn. Reson. Chem. 29 923 927 10.1002/mrc.1260290910 1:CAS:528:DyaK38XhslyhsA%3D%3D
47. S Aime M Chiaussa G Digilio E Gianolio E Terreno 1999 Contrast agents for magnetic resonance angiographic applications: H-1 and O-17 NMR relaxometric investigations on two gadolinium(III) DTPA-like chelates endowed with high binding affinity to human serum albumin J. Biol. Inorg. Chem. 4 766 774 10.1007/s007750050349 1:CAS:528:DC%2BD3cXhslWnsA%3D%3D
48. L Vander Elst F Chapelle S Laurent RN Muller 2001 Stereospecific binding of MRI contrast agents to human serum albumin: The ease of Gd-(S)-EOB DTPA (Eovist) and its (R) isomer J. Biol. Inorg. Chem. 6 196 200 10.1007/ s007750000195 1:CAS:528:DC%2BD3MXisVSrurc%3D